Add BrightSurf on Google Email

Pandemic exacerbated depression in older adults with diabetes

A recent study found that almost 50% of older adults with diabetes experienced depression during the pandemic, with loneliness and chronic pain being major risk factors. The study also identified unexpected findings, including a higher risk of depression among those with higher income prior to the pandemic.

SourceUniversity of Toronto·JournalArchives of Gerontology and Geriatrics Plus·TypeSurvey·DateJul 31, 2024

Physical activity offsets the mortality risk associated with excessive sitting time in adults with diabetes

A new study found that adults with diabetes who meet the recommended physical activity guidelines may offset the increased mortality risk associated with excessive sitting time. The study analyzed data from over 12,000 adults with diabetes and found that those who were physically active had a lower risk of death compared to those who s...

Recent insights and advances in treatment and management show promise in stemming the growing prevalence of diabetes

A recent paper surveys advances in diabetes pathogenesis and treatment, highlighting the role of genes, environmental factors, and social determinants. The study suggests that understanding these dynamics is key to developing targeted interventions to reduce diabetes risk and manage its complications.

SourceUniversity of California - Los Angeles Health Sciences·JournalCell·TypeLiterature review·DateJul 25, 2024

Older adults want to cut back on medication, but study shows need for caution

A new University of Michigan study found that over 82% of Americans aged 50-80 take one or more prescription medications, with 80% open to stopping certain drugs. However, researchers stress the importance of personalized guidance for deprescribing older adults, particularly those taking medication for cardiovascular disease or diabetes.

SourceMichigan Medicine - University of Michigan·JournalJournal of General Internal Medicine·TypeSurvey·DateJul 24, 2024

Metformin and other antidiabetic drugs can help reduce the risk of dementia in patients with type 2 diabetes

Researchers analyzed over 1.5 million patient records to find that metformin and SGLT-2 inhibitors lowered dementia and Alzheimer's disease risks compared to other antidiabetic drugs. The study suggests individualized treatment approaches considering patient-specific factors for optimal diabetes management.

SourceElsevier·JournalAmerican Journal of Preventive Medicine·TypeMeta-analysis·DateJul 11, 2024

Mount Sinai and City of Hope scientists first to demonstrate a combination treatment can increase human insulin-producing cells in vivo

Researchers from Mount Sinai and City of Hope demonstrate a combination treatment that increases human insulin-producing beta cells by 700% in mice with diabetes. This breakthrough could lead to new treatments for the hundreds of millions of people with diabetes worldwide.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalScience Translational Medicine·DateJul 10, 2024

Mount Sinai researchers unveil comprehensive youth diabetes dataset and interactive portal to boost research and prevention strategies

The Mount Sinai researchers have developed a comprehensive epidemiological dataset for youth diabetes and prediabetes research, derived from NHANES data collected from 1999 to 2018. The newly launched POND portal aims to facilitate an understanding of factors that may influence youth diabetes risk.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJMIR Public Health and Surveillance·DateJul 2, 2024

Investigating the causes of fetal growth disorders

A study found that overexpressing a gene responsible for amino acid transport in the placenta can cause fetal growth to increase by 27%, while also providing insights into pregnancy complications like IUGR and obesity. The research has therapeutic implications, potentially informing treatments to prevent or treat these conditions.

SourcePNAS Nexus·JournalPNAS Nexus·DateJun 18, 2024

Potential new treatment option for diabetic retinopathy

Researchers have developed a new treatment for diabetic retinopathy that addresses the root cause of the disease, preventing progression and potential blindness. The anti-ceramide immunotherapy has been shown to be effective in animal and cell culture models, offering a safer alternative to current treatments.

SourceUniversity of Oklahoma·JournalCell Metabolism·TypeExperimental study·DateJun 17, 2024

Brigham researchers find GLP-1 medications safe to continue before surgery in patients with diabetes and obesity

A meta-analysis of 15 randomized studies found that patients taking GLP-1 medications experienced only mild differences in gastric emptying, delaying solid food by about 36 minutes. The findings suggest it may be safe to continue these medications before surgery without a high risk of aspiration.

SourceBrigham and Women's Hospital·JournalThe American Journal of Gastroenterology·TypeRandomized controlled/clinical trial·DateJun 4, 2024

International study reveals surprising twist in how diabetes drugs help the heart

A clinical trial found that SGLT2 inhibitor drugs improve cardiac outcomes and heart health by activating a defence mechanism that abolishes potential diuretic effects. The study suggests alternative mechanisms of action, such as metabolic changes that improve organ function.

SourceDuke-NUS Medical School·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateMay 26, 2024

Can triglycerides-HDL-C ratio, HOMA-IR, ApoB, non-HDL cholesterol, and free cholesterol be laboratory-associated flags of female coronary atherosclerosis regardless of being diabetic?

Research finds insulin levels correlate with triglycerides, ApoB, non-HDL cholesterol, and free cholesterol in women with atherosclerotic coronary disease. The study suggests these laboratory-associated flags indicate early coronary atherosclerosis in both diabetic and non-diabetic women.

SourceBentham Science Publishers·JournalThe Open Biomarkers Journal·DateMay 24, 2024

Repurposed cancer drug could treat diabetes by nudging pancreatic acinar cells to produce insulin

Researchers have discovered a repurposed cancer drug that can convert acinar cells into insulin-producing cells, which could provide a new avenue for treating diabetes. The treatment partially improved hyperglycemia and persisted without additional treatment in diabetic mice and non-human primates.

SourceUniversity of Pittsburgh·JournalNature Communications·TypeExperimental study·DateMay 6, 2024

MCG scientists identify new treatment target for leading cause of blindness

Researchers at MCG's Vascular Biology Center have identified a new treatment target for age-related macular degeneration (AMD), a leading cause of blindness. Targeting the adenosine receptor 2A (Adora2a) may block excessive blood vessel growth and fibrosis, potentially offering a more efficient treatment than current therapies.

SourceMedical College of Georgia at Augusta University·JournalScience Translational Medicine·DateMay 2, 2024

Medical school scientist creates therapy to kill hypervirulent bacteria

A new therapy has been identified that can penetrate the slime protecting drug-resistant bacteria, allowing it to be killed by the body's immune system or antibiotics. The antimicrobial peptide, derived from cow peptides, targets sugar connections in the slime structure, damaging its integrity and allowing entry.

SourceUniversity of Central Florida·JournalCell Reports Physical Science·TypeExperimental study·DateMay 1, 2024